全文获取类型
收费全文 | 2153篇 |
免费 | 84篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 49篇 |
妇产科学 | 31篇 |
基础医学 | 270篇 |
口腔科学 | 38篇 |
临床医学 | 217篇 |
内科学 | 425篇 |
皮肤病学 | 30篇 |
神经病学 | 164篇 |
特种医学 | 193篇 |
外科学 | 366篇 |
综合类 | 30篇 |
一般理论 | 1篇 |
预防医学 | 75篇 |
眼科学 | 60篇 |
药学 | 163篇 |
中国医学 | 2篇 |
肿瘤学 | 143篇 |
出版年
2022年 | 10篇 |
2021年 | 21篇 |
2020年 | 12篇 |
2019年 | 19篇 |
2018年 | 28篇 |
2017年 | 13篇 |
2016年 | 38篇 |
2015年 | 38篇 |
2014年 | 41篇 |
2013年 | 58篇 |
2012年 | 78篇 |
2011年 | 98篇 |
2010年 | 47篇 |
2009年 | 52篇 |
2008年 | 86篇 |
2007年 | 84篇 |
2006年 | 104篇 |
2005年 | 77篇 |
2004年 | 61篇 |
2003年 | 63篇 |
2002年 | 61篇 |
2001年 | 85篇 |
2000年 | 65篇 |
1999年 | 62篇 |
1998年 | 32篇 |
1997年 | 23篇 |
1996年 | 38篇 |
1995年 | 25篇 |
1994年 | 47篇 |
1993年 | 18篇 |
1992年 | 45篇 |
1991年 | 41篇 |
1990年 | 56篇 |
1989年 | 54篇 |
1988年 | 64篇 |
1987年 | 64篇 |
1986年 | 66篇 |
1985年 | 49篇 |
1984年 | 21篇 |
1983年 | 26篇 |
1982年 | 24篇 |
1981年 | 16篇 |
1980年 | 13篇 |
1979年 | 20篇 |
1978年 | 17篇 |
1977年 | 18篇 |
1976年 | 18篇 |
1975年 | 17篇 |
1973年 | 13篇 |
1972年 | 12篇 |
排序方式: 共有2267条查询结果,搜索用时 62 毫秒
31.
G Mitterbauer-Hohendanner C Mannhalter K Winkler M Mitterbauer C Skrabs A Chott I Simonitsch-Klupp A Gleiss K Lechner U Jaeger 《Leukemia》2004,18(6):1102-1107
The prognostic value of the detection of peripheral blood (PB) and/or bone marrow (BM) involvement by polymerase chain reaction (PCR) amplification of rearranged immunoglobulin heavy chain (IgH) and immunoglobulin kappa light chain (Igkappa) genes was evaluated in 155 patients with diffuse large B-cell lymphomas (DLBCL). Immunoglobulin gene rearrangements (IgR) were detected in 35/155 (23%) patients. The presence of IgR in PB/BM was related to clinical stage (CS I-III vs CS IV; P<0.001), histopathological detection of BM involvement (P<0.001), and the International Prognostic Index (P<0.001). IgR-positive cases had a significantly lower complete remission (CR) rate (18/35, 51%) than IgR-negative patients (85/120, 71%; P=0.042), and a significantly poorer overall survival (OAS) at 5 years (25 vs 66%; P<0.001). There was a significant difference in the estimated OAS at 5 years between patients with negative BM histology and negative PCR results (66%), patients with negative BM histology but positive IgR (37%), and patients with positive BM histology (12%). Our results indicate that molecular methods improve the accuracy of staging in patients with DLBCL and define a group of patients with normal bone marrow histology who have a significantly poorer OAS due to molecular detection of PB/BM involvement. 相似文献
32.
Katrien De Jaeger M.D. M.Sc. Yvette Seppenwoolde Ph.D. Harm H. Kampinga Ph.D. Liesbeth J. Boersma M.D. Ph.D. Jos S. A. Belderbos M.D. Joos V. Lebesque M.D. Ph.D. 《International journal of radiation oncology, biology, physics》2004,58(5):27-1387
PURPOSE: In dose-escalation studies of radiotherapy (RT) for non-small-cell lung cancer (NSCLC), radiation pneumonitis (RP) is the most important dose-limiting complication. Transforming growth factor-beta1 (TGF-beta1) has been reported to be associated with the incidence of RP. It has been proposed that serial measurements of plasma TGF-beta1 can be valuable to estimate the risk of RP and to decide whether additional dose-escalation can be safely applied. The aim of this study was to evaluate prospectively the time course of TGF-beta1 levels in patients irradiated for NSCLC in relation to the development of RP and dose-volume parameters. METHODS AND MATERIALS: Plasma samples were obtained in 68 patients irradiated for medically inoperable or locally advanced NSCLC (dose range, 60.8-94.5 Gy) before and 4, 6, and 18 weeks after the start of RT. Plasma TGF-beta1 levels were determined using a bioassay on the basis of TGF-beta1-induced plasminogen activator inhibitor-1 expression in mink lung cells. All patients underwent chest computed tomography scans before RT that were repeated at 18 weeks after RT. The computed tomography data were used to calculate the mean lung dose (MLD) and to score the radiation-induced radiologic changes. RP was defined on the basis of the presence of either radiographic changes or clinical symptoms. Symptomatic RP was scored according to the Common Toxicity Criteria (Grade 1 or worse) and the Southwestern Oncology Group criteria (Grade 2 or worse). Multivariate analyses were performed to investigate which factors (pre- or posttreatment TGF-beta1 level, MLD) were associated with the incidence of RP. To improve our understanding of the time course of TGF-beta1 levels, we performed a multivariate analysis to investigate which factors (pre-RT TGF-beta1 level, MLD, RP) were independently associated with the posttreatment TGF-beta1 levels. RESULTS: The pre-RT TGF-beta1 levels were increased in patients with NSCLC (median 21 ng/mL, range, 5-103 ng/mL) compared with healthy individuals (range, 4-12 ng/mL). On average, the TGF-beta1 levels normalized toward the end of treatment and remained stable until 18 weeks after RT. In 29 patients, however, TGF-beta1 was increased at the end of RT with respect to the pre-RT value. The multivariate analyses revealed that the MLD was the only variable that correlated significantly with the risk of both radiographic RP (p = 0.05) and symptomatic RP, independent of the scoring system used (p = 0.05 and 0.03 for Southwestern Oncology Group and Common Toxicity Criteria systems, respectively). The TGF-beta1 level at the end of RT was significantly associated with the MLD (p <0.001) and pre-RT TGF-beta1 level (p = 0.001). CONCLUSION: The MLD correlated significantly with the incidence of both radiographic and symptomatic RP. The results of our study did not confirm the reports that increased levels of TGF-beta1 at the end of RT are an independent additional risk factor for developing symptomatic RP. However, the TGF-beta1 level at the end of a RT was significantly associated with the MLD and the pre-RT level. 相似文献
33.
Katrien De Jaeger Mischa S Hoogeman Martijn Engelsman Yvette Seppenwoolde Eugène M F Damen Ben J Mijnheer Liesbeth J Boersma Joos V Lebesque 《Radiotherapy and oncology》2003,69(1):1-10
BACKGROUND AND PURPOSE: The low density of lung tissue causes a reduced attenuation of photons and an increased range of secondary electrons, which is inaccurately predicted by the algorithms incorporated in some commonly available treatment planning systems (TPSs). This study evaluates the differences in dose in normal lung tissue computed using a simple and a more correct algorithm. We also studied the consequences of these differences on the dose-effect relations for radiation-induced lung injury. MATERIALS AND METHODS: The treatment plans of 68 lung cancer patients initially produced in a TPS using a calculation model that incorporates the equivalent-path length (EPL) inhomogeneity-correction algorithm, were recalculated in a TPS with the convolution-superposition (CS) algorithm. The higher accuracy of the CS algorithm is well-established. Dose distributions in lung were compared using isodoses, dose-volume histograms (DVHs), the mean lung dose (MLD) and the percentage of lung receiving >20 Gy (V20). Published dose-effect relations for local perfusion changes and radiation pneumonitis were re-evaluated. RESULTS: Evaluation of isodoses showed a consistent overestimation of the dose at the lung/tumor boundary by the EPL algorithm of about 10%. This overprediction of dose was also reflected in a consistent shift of the EPL DVHs for the lungs towards higher doses. The MLD, as determined by the EPL and CS algorithm, differed on average by 17+/-4.5% (+/-1SD). For V20, the average difference was 12+/-5.7% (+/-1SD). For both parameters, a strong correlation was found between the EPL and CS algorithms yielding a straightforward conversion procedure. Re-evaluation of the dose-effect relations showed that lung complications occur at a 12-14% lower dose. The values of the TD(50) parameter for local perfusion reduction and radiation pneumonitis changed from 60.5 and 34.1 Gy to 51.1 and 29.2 Gy, respectively. CONCLUSIONS: A simple tissue inhomogeneity-correction algorithm like the EPL overestimates the dose to normal lung tissue. Dosimetric parameters for lung injury (e.g. MLD, V20) computed using both algorithms are strongly correlated making an easy conversion feasible. Dose-effect relations should be refitted when more accurate dose data is available. 相似文献
34.
José S A Belderbos Katrien De Jaeger Wilma D Heemsbergen Yvette Seppenwoolde Paul Baas Liesbeth J Boersma Joos V Lebesque 《Radiotherapy and oncology》2003,66(2):119-126
PURPOSE: To evaluate the feasibility of dose escalation in non-small cell lung cancer (NSCLC) using three-dimensional conformal radiation therapy. PATIENTS AND METHODS: The main eligibility criteria of the trial were: pathologically proven inoperable NSCLC, ECOG performance status or=grade 3 (SWOG), grade 3 early and grade 2 late esophageal toxicity or any other (RTOG) grade 3 or 4 complications). RESULTS: Fifty-five patients were included. Tumor stage was I/II in 47%, IIIA in 33% and IIIB in 20%. The majority of the patients received a dose of 74.3 Gy (n=17) or 81.0 Gy (n=23). Radiation pneumonitis occurred in seven patients: four patients developed a grade 2, two patients grade 3 and one patient a grade 4. Esophageal toxicity was mild. In 50 patients tumor response at 3 months follow-up was evaluable. In six patients a complete response was recorded, in 38 a partial response, five patients had stable disease and one patient experienced progressive disease. Only one patient developed an isolated failure in an uninvolved nodal area. So far the radiation dose was safely escalated to 87.8 Gy in group 1 (lowest rMLD), 81.0 Gy in groups 2 and 3 and 74.3 Gy in group 4. CONCLUSION: Three-dimensional conformal radiotherapy enables significant dose escalation in NSCLC. The maximum tolerable dose has not yet been reached in any risk group. 相似文献
35.
A 4-year-old boy presented with acute abdominal pain and a 1-year history of intermittent umbilical complaints. Ultrasonographic
examination demonstrated a large cyst in the lower abdomen divided by a thin membrane. With micturition, impaired bladder
function was expected. Initial suprapubic drainage produced 1,000 ml dark-brown liquid. Laparotomy revealed an ileal duplication
cyst. Preoperative computed tomography and laparoscopy with the cyst drained did not further clarify the diagnosis.
Accepted: 5 August 1997 相似文献
36.
There have been significant improvements in the prognosis for patients suffering from hydrocephalus stemming from the introduction of the cerebrospinal fluid (CSF) shunt some 40 years ago. Currently, one of the major obstacles to effective shunt treatment is the mismatch between the physiology of the patient and the hydraulics of the shunt system. In order to maintain the proper relationship between CSF and cerebrovascular pressures, the implanted shunt needs to establish normal CSF outflow (absorption) and storage (compliance). Many of today's shunts establish a limited range of normal CSF outflow (absorption) and storage (compliance) once implanted, but a mismatch between CSF and cerebrovascular pressures may exist when the patient changes body position during daily activities. An uncoupling of these pressures creates mechanical strains within cerebral tissues, which are implicated in pathologies related to shunt malfunction. We suggest that re-establishment of normal CSF outflow resistance, which by definition is an indicator of both absorption and compliance, is a fundamental requirement for shunt treatment under most conditions. 相似文献
37.
Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma. 总被引:4,自引:0,他引:4
Markus Raderer Stefan W?hrer Rupert Bartsch Gerald Prager Johannes Drach Michael Hejna Alexander Gaiger Karl Turetschek Ulrich Jaeger Berthold Streubel Christoph C Zielinski 《Journal of clinical oncology》2005,23(33):8442-8446
PURPOSE: Various chemotherapeutic regimens have been applied for treatment of mucosa-associated lymphoid tissue (MALT) lymphoma, but no standard regimen has been identified to date. In view of the activity of oxaliplatin (L-OHP) in various types of lymphoma, we performed a phase II study to evaluate the activity of L-OHP for treatment of MALT lymphoma. The primary objective of this study was to determine the objective response rate according to WHO standard criteria. PATIENTS AND METHODS: A total of 16 patients with MALT lymphoma of various sites of origin (four of the ocular adnexa, five of the salivary glands, three of the stomach, two of the lung, and one of the colon and the breast) were administered L-OHP at a dose of 130 mg/m2 infused during 2 hours every 3 weeks. Restaging was performed every two cycles; treatment was continued until complete remission (CR) or for a maximum of six cycles in responders. RESULTS: Sixty-five cycles were administered (median, four; range, two to six); toxicity consisted of transient sensory neuropathy in eight patients and nausea/emesis WHO grade 2 in two patients, whereas hematologic adverse effects (thrombocytopenia and leukocytopenia grade 2) occurred in only one patient each. Fifteen patients responded to chemotherapy, with nine achieving CR (56%), six (37.5%) achieving partial response, and one achieving stable disease; the median time to response was 4 months (range; 2 to 4 months). CONCLUSION: These data suggest L-OHP is a highly active agent for treatment of MALT lymphoma. However, a longer follow-up is needed to judge whether these remissions are durable. 相似文献
38.
39.
Philip Fleckman Karin Jaeger Kathleen A. Silva John P. Sundberg 《Anatomical record (Hoboken, N.J. : 2007)》2013,296(3):521-532
Recent studies of mice with hair defects have resulted in major contributions to the understanding of hair disorders. To use mouse models as a tool to study nail diseases, a basic understanding of the similarities and differences between the human and mouse nail unit is required. In this study we compare the human and mouse nail unit at the macroscopic and microscopic level and use immunohistochemistry to determine the keratin expression patterns in the mouse nail unit. Both species have a proximal nail fold, cuticle, nail matrix, nail bed, nail plate, and hyponychium. Distinguishing features are the shape of the nail and the presence of an extended hyponychium in the mouse. Expression patterns of most keratins are similar. These findings indicate that the mouse nail unit shares major characteristics with the human nail unit and overall represents a very similar structure, useful for the investigation of nail diseases and nail biology. Anat Rec, 296:521–532, 2013. © 2013 Wiley Periodicals, Inc. 相似文献
40.
Dominik Schori Matthias Jaeger Timon Elmer Susanne Jaeger Candelaria Mahlke Kolja Heumann Anastasia Theodoridou Gianfranco Zuaboni Bernd Kozel Franziska Rabenschlag 《Archives of Psychiatric Nursing》2018,32(5):662-669
Treatment pressure restricts patients' voluntary and autonomous decisions. Yet interventions involving treatment pressure are widely used in mental health and psychosocial services. This cross-sectional study explored whether mental health professionals' knowledge on five types of treatment pressure (no coercion, persuasion or conviction, leverage, threat, and formal coercion) was associated with sociodemographic, professional and contextual factors. A more positive attitude towards interventions involving treatment pressure was associated with underrating the level of those interventions compared with a predefined default value. The treatment setting and professional group played a minor role in ‘leverage’ and ‘formal coercion’ types of treatment pressure, respectively. 相似文献